Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
18.85
+1.30 (7.41%)
Apr 30, 2026, 3:03 PM EDT - Market open
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.12 billion as of April 30, 2026. Its market cap has increased by 238.28% in one year.
Market Cap
1.12B
Enterprise Value
752.67M
1-Year Change
238.28%
Ranking
Category
Stock Price
$18.85
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.12B, an increase of 65.76%. That is a compound annual growth rate of 36.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.07B | -45.03% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.17B |
| MoonLake Immunotherapeutics | 1.17B |
| Pharming Group | 1.17B |
| UroGen Pharma | 1.14B |
| Jade Biosciences | 1.12B |
| EyePoint | 1.09B |
| Omeros | 1.07B |
| Septerna | 1.06B |